BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Germano D, Daniele B. Systemic therapy of hepatocellular carcinoma: Current status and future perspectives. World J Gastroenterol 2014; 20(12): 3087-3099 [PMID: 24696596 DOI: 10.3748/wjg.v20.i12.3087]
URL: https://www.wjgnet.com/1007-9327/full/v20/i12/3087.htm
Number Citing Articles
1
GANG HUANG, LIMEI LI, WEIPING ZHOU. USP14 activation promotes tumor progression in hepatocellular carcinomaOncology Reports 2015; 34(6): 2917 doi: 10.3892/or.2015.4296
2
Junying Wang, Daniel J. McGrail, Parnit K. Bhupal, Wen Zhang, Kuan-Yu Lin, Yi-Hsuan Ku, Tao Lin, Hongfu Wu, Kyle C. Tsai, Kaiyi Li, Cheng-Yuan Peng, Milton J. Finegold, Shiaw-Yih Lin, Robert Y.L. Tsai. Nucleostemin Modulates Outcomes of Hepatocellular Carcinoma via a Tumor Adaptive Mechanism to Genomic StressMolecular Cancer Research 2020; 18(5): 723 doi: 10.1158/1541-7786.MCR-19-0777
3
Gayatri Gouda, Manoj Kumar Gupta, Ravindra Donde, Lambodar Behera, Ramakrishna Vadde. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma2022; : 109 doi: 10.1016/B978-0-323-98806-3.00007-6
4
Lei-Bo Xu, Chao Liu. Role of liver stem cells in hepatocarcinogenesisWorld Journal of Stem Cells 2014; 6(5): 579-590 doi: 10.4252/wjsc.v6.i5.579
5
Xiangdan Cui, Aijun Zhang, Jianwei Liu, Kangkang Wu, Zhengfeng Chen, Qing Wang. Down-regulation of MAP2K1 by miR-539 inhibits hepatocarcinoma progressionBiochemical and Biophysical Research Communications 2018; 504(4): 784 doi: 10.1016/j.bbrc.2018.08.076
6
Jianting Long, Chunlin Jiang, Baoxian Liu, Shi Fang, Ming Kuang. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNFTumor Biology 2016; 37(5): 5821 doi: 10.1007/s13277-015-4427-6
7
Abdel Hady A. Abdel Wahab, Medhat S. El-Halawany, Ahmad A. Emam, Ammar Elfiky, Zakaria Y. Abd Elmageed. Identification of circulating protein biomarkers in patients with hepatocellular carcinoma concomitantly infected with chronic hepatitis C virusBiomarkers 2016; : 1 doi: 10.1080/1354750X.2016.1252966
8
Javier Tejeda-Maldonado, Ignacio García-Juárez, Jonathan Aguirre-Valadez, Adrián González-Aguirre, Mario Vilatobá-Chapa, Alejandra Armengol-Alonso, Francisco Escobar-Penagos, Aldo Torre, Juan Francisco Sánchez-Ávila, Diego Luis Carrillo-Pérez. Diagnosis and treatment of hepatocellular carcinoma: An updateWorld Journal of Hepatology 2015; 7(3): 362-376 doi: 10.4254/wjh.v7.i3.362
9
Femke Heindryckx, Pär Gerwins. Targeting the tumor stroma in hepatocellular carcinomaWorld Journal of Hepatology 2015; 7(2): 165-176 doi: 10.4254/wjh.v7.i2.165
10
Min‐Seok Park, Nan‐Hee Kim, Chang‐Won Kang, Chul‐Woong Oh, Gun‐Do Kim. Antimetastatic Effects of Gambogic Acid are Mediated via the Actin Cytoskeleton and NF‐κB Pathways in SK‐HEP1 CellsDrug Development Research 2015; 76(3): 132 doi: 10.1002/ddr.21249
11
Iu. S. Taskaeva, N. P. Bgatova, A. O. Solovieva. Autophagy in Hepatocellular Carcinoma-29 after Single or Combined Administration of Lithium Carbonate and RapamycinCell and Tissue Biology 2019; 13(5): 353 doi: 10.1134/S1990519X19050079
12
Sebastian Lünse, Claus-Dieter Heidecke, Lars Ivo Partecke. Hepatocellular Carcinoma2019; : 111 doi: 10.15586/hepatocellularcarcinoma.2019.ch6
13
Samantha Armstrong, Tina Roy, Bhavana Singh, Monika Kulasekaran, Fatima Shaukat, Xue Geng, Hongkun Wang, Petra Prins, Reena C. Jha, Marion L. Hartley, Aiwu Ruth He. TKIs beyond immunotherapy predict improved survival in advanced HCCJournal of Cancer Research and Clinical Oncology 2023; 149(6): 2559 doi: 10.1007/s00432-022-04115-w
14
Senem Demir, Cigdem Özen, Meltem Ceylan‐Ünlüsoy, Mehmet Öztürk, Oya Bozdağ‐Dündar. Novel Furochromone Derivatives: Synthesis and Anticancer Activity StudiesJournal of Heterocyclic Chemistry 2019; 56(4): 1341 doi: 10.1002/jhet.3508
15
Ji-sheng Jing, Hongbo Li, Shun-cai Wang, Jiu-ming Ma, La-qing Yu, Hua Zhou. NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinomaBioscience Reports 2018; 38(6) doi: 10.1042/BSR20180907
16
LEI ZHANG, YI LI, LIANG QIAO, YONGXUN ZHAO, YUCAI WEI, YUMIN LI. Protective effects of hepatic stellate cells against cisplatin-induced apoptosis in human hepatoma G2 cellsInternational Journal of Oncology 2015; 47(2): 632 doi: 10.3892/ijo.2015.3024
17
James Ronald, Andrew B. Nixon, Daniele Marin, Rajan T. Gupta, Gemini Janas, Willa Chen, Paul V. Suhocki, Waleska Pabon-Ramos, David R. Sopko, Mark D. Starr, John C. Brady, Herbert I. Hurwitz, Charles Y. Kim. Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular CarcinomaRadiology 2017; 285(1): 311 doi: 10.1148/radiol.2017162555
18
G.J. Wengert, H. Bickel, J. Breitenseher, A. Ba-Ssalamah. Primäre LebertumorenDer Radiologe 2015; 55(1): 27 doi: 10.1007/s00117-014-2705-8
19
Lili Cao, Lijun Zhang, Xiang Zhao, Ye Zhang, Daolin Tang. A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma CellsPLOS ONE 2016; 11(8): e0161025 doi: 10.1371/journal.pone.0161025
20
Bader Abdelmaksoud. Safety and Efficacy of Continuous Low-dose Doxorubicin and Fluorouracil (5FU) with Best Supportive Care Compared to Best Standard of Care alone for Patients with Advanced Hepatocellular CarcinomaInternational Journal of Cancer and Oncology 2017; 4(1): 1 doi: 10.15436/2377-0902.16.1194
21
Lorena Rico, Michael E. Østergaard, Melanie Bell, Punit P. Seth, Stephen Hanessian. Studies directed toward the asialoglycoprotein receptor mediated delivery of 5-fluoro-2′-deoxyuridine for hepatocellular carcinomaBioorganic & Medicinal Chemistry Letters 2018; 28(15): 2652 doi: 10.1016/j.bmcl.2018.06.002
22
Mahmoud M. Kamel, Mohamed F. Saad, Amal A. Mahmoud, Awatief A. Edries, Ahmed S. Abdel-Moneim. Evaluation of serum PIVKA-II and MIF as diagnostic markers for HCV/HBV induced hepatocellular carcinomaMicrobial Pathogenesis 2014; 77: 31 doi: 10.1016/j.micpath.2014.10.009
23
Xuefeng Gu, Hongbo Li, Ling Sha, Wei Zhao. A prognostic model composed of four long noncoding RNAs predicts the overall survival of Asian patients with hepatocellular carcinomaCancer Medicine 2020; 9(16): 5719 doi: 10.1002/cam4.3275
24
Quanwu Su, Hongxia Wang. Long non-coding RNA 01559 mediates the malignant phenotypes of hepatocellular carcinoma cells through targeting miR-511Clinics and Research in Hepatology and Gastroenterology 2021; 45(2): 101648 doi: 10.1016/j.clinre.2021.101648
25
Cigdem Ozen, Meltem Ceylan-Unlusoy, Mehmet Ozturk, Oya Bozdag-Dundar. A novel chromonyl thiohydantoin with anti-proliferative action on primary hepatocellular carcinoma cellsMedicinal Chemistry Research 2018; 27(1): 153 doi: 10.1007/s00044-017-2037-0
26
Yannan Zheng, Wenhui Zhang, Lin Xu, Hua Zhou, Man Yuan, Hongxi Xu. Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver CancerFrontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.795548
27
Jan Erik Slotta, Otto Kollmar, Volker Ellenrieder, B Michael Ghadimi, Kia Homayounfar. Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectivesWorld Journal of Hepatology 2015; 7(9): 1168-1183 doi: 10.4254/wjh.v7.i9.1168
28
Xiaoyun Dai, Kwang Seok Ahn, Ling Zhi Wang, Chulwon Kim, Amudha Deivasigamni, Frank Arfuso, Jae-Young Um, Alan Prem Kumar, Young-Chae Chang, Dhiraj Kumar, Gopal C. Kundu, Junji Magae, Boon Cher Goh, Kam Man Hui, Gautam Sethi. Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular CarcinomaMolecular Cancer Therapeutics 2016; 15(12): 2966 doi: 10.1158/1535-7163.MCT-16-0391
29
Yuwen Wang, Shujun Zhang, Jia Liu, Biaobiao Fang, Jie Yao, Binglin Cheng. Matrine inhibits the invasive and migratory properties of human hepatocellular carcinoma by regulating epithelial‑mesenchymal transitionMolecular Medicine Reports 2018;  doi: 10.3892/mmr.2018.9023
30
Youmei Peng, Wenquan Yu, Ertong Li, Jinfeng Kang, Yafeng Wang, Qinghua Yang, Bingjie Liu, Jingmin Zhang, Longyu Li, Jie Wu, Jinhua Jiang, Qingduan Wang, Junbiao Chang. Discovery of an Orally Active and Liver-Targeted Prodrug of 5-Fluoro-2′-Deoxyuridine for the Treatment of Hepatocellular CarcinomaJournal of Medicinal Chemistry 2016; 59(8): 3661 doi: 10.1021/acs.jmedchem.5b01807
31
Medhat S. El-Halawany, Heba M. Ismail, Ahmed A. Zeeneldin, Ammar Elfiky, Marwa Tantawy, Mohamed H. Kobaisi, Ikram Hamed, Abdel Hady A. Abdel Wahab. Investigating the Pretreatment miRNA Expression Patterns of Advanced Hepatocellular Carcinoma Patients in Association with Response to TACE TreatmentBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/649750
32
Siqi Liao, Qingliang Wang, Siyuan Chen, Qixuan Huang, Li Zhou, Hongtao Liu, Song He, Zhihang Zhou. Mito-LND and (E)-Akt inhibitor-IV: novel compounds inducing endoplasmic reticulum stress and ROS accumulation against hepatocellular carcinomaJournal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05545-5
33
Peng Zhao, Li Chen, Lin-Hu Li, Zhi-Feng Wei, Bei Tong, Yu-Gai Jia, Ling-Yi Kong, Yu-Feng Xia, Yue Dai. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activationBMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-987